Empagliflozin in Patients with Chronic Kidney Disease. (2023)
Attributed to:
Randomised trials in cardiovascular and metabolic disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1056/nejmoa2204233
PubMed Identifier: 36331190
Publication URI: http://europepmc.org/abstract/MED/36331190
Type: Journal Article/Review
Volume: 388
Parent Publication: The New England journal of medicine
Issue: 2
ISSN: 0028-4793